ArticlePloS one2021

A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis.

Michael I Dorrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.